Arkolith/Insider Trading/AADI/Form 4

Desai Neil

EXECUTIVE CHAIRMAN, DirectorAadi Bioscience, Inc. (AADI) · full profile →Form 4 · filed Jul 2, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$57K
Net Open-Market Flow
-$57K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 2, 2024Sell(S)9K$1.34$12K1.3M
Jul 1, 2024Sell(S)31K$1.45$45K1.3M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-019045) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML